Archive for the ‘Bipolar Disorder’ Category

The Virginia Tech Massacre Revisited

By MedHeadlines • May 8th, 2008 • Category: Bipolar Disorder, Depression, Lifestyle, Prevention, Psychology

On April 16, 2007 23-year-old Seung-Hui Cho, a student at Virginia Tech University in Blacksburg, Virginia, USA, shot to death 32 students and faculty members, wounded many more, and then committed suicide. From an early age Cho was seen to…



Researchers Remain Undecided About Omega-3s Effects On Bipolar Disorder

By MedHeadlines • Apr 29th, 2008 • Category: Bipolar Disorder, Prevention, Supplements

Although there is significant clinical evidence to support using omega-3 fatty acid supplements for the treatment of depression symptoms, the supplement’s role in treating bipolar disorder is still undecided. Researchers do believe, however, that further studies should be conducted since…



Could Schizophrenia Be Entirely Genetic?

By MedHeadlines • Mar 29th, 2008 • Category: Bipolar Disorder, Family, Genetic Diseases, Headlines, Medical Research, Neurology, Psychology, Schizophrenia

The latest gene-scanning technology may have shed some much-desired light on a potential cause for schizophrenia, a mental disorder characterized by delusions and scrambled thought processes. The disease is believed to affect 1% of the population.



Common Schizophrenia Drug on Trial

By MedHeadlines • Mar 8th, 2008 • Category: Bipolar Disorder, Diabetes, Drugs, FDA, Prevention, Schizophrenia

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of…



ABILIFY Now Available for Younger Patients with Bipolar Disorder

By MedHeadlines • Mar 3rd, 2008 • Category: Bipolar Disorder, Children's Health, Drugs, FDA, Prevention

Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company have announced that a new drug for treatment of bipolar disorder in children and adolescents is now available. ABILIFY (aripiprazole) has been approved by the FDA for patients 10 to 17 years…